Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

116.25
Delayed Data
As of 4:02pm ET
 +0.19 / +0.16%
Today’s Change
92.28
Today|||52-Week Range
148.00
+10.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues233.8M228.8M220.4M196.4M
 
 
 
 
 
Cost of Goods Sold47.2M47.7M49.4M48.7M
 
 
 
 
 
Depreciation And Amortization3.7M3.7M3.7M3.8M
 
 
 
 
 
 
Operating ExpensesGross Income182.9M177.4M167.3M143.9M
 
 
 
 
 
General Expenses40.2M35.7M38.3M42.1M
 
 
 
 
 
Research And Development17.9M14.8M18.0M19.9M
 
 
 
 
 
Total Operating Expenses91.1M87.2M91.4M94.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income142.7M141.6M129.0M101.8M
 
 
 
 
 
Extraordinary Charge-108.0K-76.0K0.00-92.0K
 
 
 
 
Other Expenses-2.2M18.0M31.5M-5.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income140.4M159.5M160.5M100.3M
 
 
 
 
 
Income Taxes-30.4M-35.6M-20.5M-17.3M
 
 
 
 
 
Minority Interest-4.0K-243.0K-94.0K-23.0K
 
 
 
 
 
Discontinued Operations-101.0K-76.0K-137.0K-38.0K
 
 
 
 
 
Net Income109.9M123.7M139.8M83.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.4M41.3M41.0M40.6M
 
 
 
 
 
Shares To Calculate EPS Diluted42.4M41.3M41.0M40.6M
 
 
 
 
 
 
Earnings Per ShareEPS$2.59$3.00$3.42$2.05
 
 
 
 
 
EPS Diluted$2.59$2.99$3.41$2.05